paclitaxel
Showing 1 - 25 of 1,742
Chemo-induced Peripheral Neuropathy Trial (Curcumin, Paclitaxel)
Not yet recruiting
- Chemotherapy-induced Peripheral Neuropathy
- Curcumin
- Paclitaxel
- (no location specified)
Jul 21, 2023
Gastroesophageal Adenocarcinoma Trial (Paclitaxel, Ramucirumab, Zanidatamab)
Not yet recruiting
- Gastroesophageal Adenocarcinoma
- Paclitaxel
- +2 more
- (no location specified)
Sep 12, 2023
Recurrent Ovarian Cancer, Recurrent Uterine Cancer, Metastatic Cancer Trial in Toronto (RP-6306, Carboplatin, Paclitaxel)
Not yet recruiting
- Recurrent Ovarian Cancer
- +3 more
- RP-6306
- +2 more
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Oct 25, 2023
Gastric Adenocarcinoma, Carcinomatosis Trial in Houston (Paclitaxel, Dexamethasone, Diphenhydramine)
Not yet recruiting
- Gastric Adenocarcinoma
- Carcinomatosis
- Paclitaxel
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Aug 7, 2023
Gastric Adenocarcinoma, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Chuo Ku (TRK-950, Ramucirumab,
Not yet recruiting
- Gastric Adenocarcinoma
- +2 more
- TRK-950
- +2 more
-
Chuo Ku, JapanOsaka International Cancer Institute
Sep 14, 2023
Advanced Lung Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8, Stage IIIC Lung Cancer AJCC v8 Trial (drug, procedure,
Not yet recruiting
- Advanced Lung Non-Small Cell Carcinoma
- +3 more
- Carboplatin
- +9 more
- (no location specified)
Oct 21, 2023
Head and Neck Squamous Cell Carcinoma Trial in United States (TAK-676, Carboplatin, 5-FU)
Completed
- Head and Neck Squamous Cell Carcinoma
- TAK-676
- +8 more
-
Shreveport, Louisiana
- +3 more
Oct 3, 2023
Breast Carcinoma Trial in Houston (biological, drug, other)
Not yet recruiting
- Breast Carcinoma
- eftilagimod alpha
- +2 more
-
Houston, TexasOncology Consultants
Feb 17, 2023
Gastric Cancer Trial in Tianjin (AK104, Apatinib, Paclitaxel)
Recruiting
- Gastric Cancer
- AK104
- +3 more
-
Tianjin, ChinaTianjin Medical University Cancer Institute and Hospital
May 7, 2023
Breast - Female, Male Breast Cancer Trial in Charlotte (Pembrolizumab, Paclitaxel)
Completed
- Breast - Female
- Male Breast Cancer
- Pembrolizumab
- Paclitaxel
-
Charlotte, North CarolinaLevine Cancer Institute
Jan 25, 2023
Triple Negative Metastatic Breast Cancer, Advanced Ovarian Cancer, Carboplatin Trial in Belgium, Netherlands, United Kingdom
Active, not recruiting
- Triple Negative Metastatic Breast Cancer
- +3 more
- KU-0059436 (AZD2281)(PARP inhibitor)
- +3 more
-
Brussels, Belgium
- +3 more
Dec 19, 2022
Kaposi Sarcoma, HIV-1-infection Trial (Pegylated liposomal doxorubicin, Paclitaxel)
Not yet recruiting
- Kaposi Sarcoma
- HIV-1-infection
- Pegylated liposomal doxorubicin
- Paclitaxel
- (no location specified)
Jan 20, 2023
Esophageal Squamous Cell Cancer Trial in Beijing (Toripalimab, Paclitaxel, Cisplatin)
Recruiting
- Esophageal Squamous Cell Cancer
- Toripalimab
- +2 more
-
Beijing, Beijing, ChinaBeijing Cancer Hospital / Peking University Cancer Hospital
Jan 30, 2023
Anatomic Stage IV Breast Cancer AJCC v8, Chemo-Induced Peripheral Neuropathy, Metastatic Breast Carcinoma Trial (Paclitaxel,
Not yet recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- +2 more
- Paclitaxel
- +4 more
- (no location specified)
Feb 21, 2023
Lung Cancer Trial in Carlsbad, Cleveland (ISIS 3521, carboplatin, paclitaxel)
Completed
- Lung Cancer
- ISIS 3521
- +2 more
-
Carlsbad, California
- +1 more
Dec 1, 2022
Recurrent High Grade Uterine Cancer Trial in United States (Paclitaxel, Batiraxcept)
Not yet recruiting
- Recurrent High Grade Uterine Cancer
- Paclitaxel
- Batiraxcept
-
San Francisco, California
- +3 more
Apr 11, 2023
Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial (Ramucirumab, Paclitaxel)
No longer available
- Gastric Cancer
- Gastroesophageal Junction Adenocarcinoma
- Ramucirumab
- Paclitaxel
- (no location specified)
Jan 17, 2023
Gastrointestinal Stromal Tumors Trial in Seoul (Paclitaxel)
Recruiting
- Gastrointestinal Stromal Tumors
- Paclitaxel
-
Seoul, Korea, Republic ofAsan Medical Center
Dec 30, 2022
Ovarian Cancer Trial in Houston (Paclitaxel, Bevacizumab, Lurbinectedin)
Not yet recruiting
- Ovarian Cancer
- Paclitaxel
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Nov 23, 2022
Gastric Adenocarcinoma, Gastric Cancer, Esophagogastric Junction Trial run by the NCI (Paclitaxel, Capecitabine, BardPort
Recruiting
- Gastric Adenocarcinoma
- +3 more
- Paclitaxel
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 31, 2023
Advanced Cancer Trial in Houston (Dasatinib, Bevacizumab, Paclitaxel)
Completed
- Advanced Cancer
- Dasatinib
- +2 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Nov 21, 2022
Adult Solid Tumor Trial in Chicago (Carboplatin, Laboratory Biomarker Analysis, Paclitaxel)
Active, not recruiting
- Adult Solid Neoplasm
- Carboplatin
- +4 more
-
Chicago, IllinoisUniversity of Chicago Comprehensive Cancer Center
Jan 25, 2023